Charles Kaplan

Company: Kyverna Therapeutics
Job title: Vice President, Immunology
Seminars:
Developing synReg T Cells: Synthetic Tregs Targeted to Disease Tissues & Cells to Provide Transformative Treatments For Autoimmune Diseases 11:30 am
Creating synthetic Tregs by reprogramming CD4 T cells Sharing cell engineering strategies to direct synthetic Tregs to home to disease tissues and cells Developing a robust synReg manufacturing processRead more
day: Day Two | Track A | Morning